Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
MOLECULAR CANCER THERAPEUTICS
Authors: Ho, Sun K.; Xu, Zhenghai; Thakur, Archana; Fox, Melvin; Tan, Siu Sze; DiGiammarino, Enrico; Zhou, Li; Sho, Mien; Cairns, Belinda; Zhao, Vivian; Xiong, Mengli; Samayoa, Josue; Forsyth, Charles M.; Powers, David B.; Chao, Debra T.; Hollenbaugh, Diane; Alvarez, Hamsell M.; Akamatsu, Yoshiko
Abstract
CD137 (TNFRSF9, 4-1BB) agonist antibodies ( mAb) have demonstrated potent antitumor activity with memory response while causing hepatotoxicity in mouse models. In clinical trials, the degrees of liver toxicity of anti-CD137 vary from grade 4 transaminitis (urelumab) to nonexistent (utomilumab). To exploit the antitumor potential of CD137 signaling, we identified a new class of CD137 agonist mAbs with strong antitumor potency without significant transaminitis in vivo compared with CD137 agonists previously reported. These mAbs are crossreactive to mouse and cynomolgus monkey and showed cross-linking-dependent T-cell costimulation activity in vitro. Antitu-mor efficacy was maintained in Fc gamma receptor (Fc gamma R) III-deficient mice but diminished in Fc gamma RIIB-deficient mice, suggesting the critical role for Fc gamma RIIB to provide cross-linking in vivo. Interestingly, a single dose of an affinity-reduced variant was sufficient to control tumor growth, but a higher affinity variant did not improve efficacy. These observations suggest that binding epitope and Fc gamma R interaction, but not necessarily high affinity, are important for antitumor efficacy and reduced liver toxicity of CD137 mAb. Our study suggests the possibility of CD137 agonist therapy with improved safety profile in humans.
Dataset of proinflammatory cytokine and cytokine receptor gene expression in rainbow trout (Oncorhynchus mykiss) measured using a novel GeXP multiplex, RT-PCR assay
DATA IN BRIEF
Authors: Kutyrev, Ivan; Cleveland, Beth; Leeds, Timothy; Wiens, Gregory D.
Abstract
A GeXP multiplex, RT-PCR assay was developed and optimized that simultaneously measures expression of a suite of immune-relevant genes in rainbow trout (Oncorhynchus mykiss), concentrating on tumor necrosis factor and interleukin-1 ligand/receptor systems and acute phase response genes. The dataset includes expression values for drpt, il11a, il1b1, il1b2, il1b3, il1r-like-1(e3-5), il1r-like-1 (e9-11), il1r1-like-a, il1r1-like-b, il1r2, saa, tnfa1, tnfa2, tnfa3, tnfrsf1a, trifrsf1a-like-a, tnfrsf1a-like-b, tnfrsf5, and tnfrsf9. Gene expression was measured at four time-points post-challenge in both a resistant line (ARS-Fp-R) and a susceptible line (ARS-Fp-S) of rainbow trout. In addition, fish body weight, spleen index and the Flayobacterium psychrophilum load are reported. These data are an extension of information presented and discussed in "Proinflammatory cytokine and cytokine receptor gene expression kinetics following challenge with Flayobacteriurn psychrophilum in resistant and susceptible lines of rainbow trout (Oncorhynchus mykiss)" (Kutyrev et al., 2016) [1]. Published by Elsevier Inc.